MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
基本信息
- 批准号:7759364
- 负责人:
- 金额:$ 12.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAffinityAllelesAnimalsAntibodiesAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiological MarkersCD4 Positive T LymphocytesCD8 AntigensCD8-Positive T-LymphocytesCD8B1 geneCell Differentiation processCell physiologyCell surfaceCellsComplexDependenceDevelopmentDisease ProgressionDoctor of PhilosophyEctopic ExpressionEssential GenesFamilyGenerationsGenesGeneticGenetic ModelsGerm LinesHomeostasisHumanIL2RA geneImmuneImmune responseIn VitroInfectionInflammationInflammatoryLinkLymphoproliferative DisordersMHC Class II GenesMeasuresMediatingMessenger RNAModelingMolecularMolecular TargetMusMutant Strains MiceMutationNeonatalNumbersOrganPathologyPatientsPeptide/MHC ComplexPeripheralPlayPopulationProcessProteinsRegulationReporterRoleSeveritiesSyndromeT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsTestingThymus GlandTumor Necrosis Factor ReceptorWood materialanergyautoreactive T cellautoreactivityforkhead proteinin vivomRNA Expressionmemberprogramsthymocyte
项目摘要
DESCRIPTION (provided by applicant): Naturally arising regulatory CD25+ CD4 T cells play an essential role in regulation of immune homeostasis. However, specific molecular mechanisms regulating their differentiation and activity have been largely unknown. We have found that forkhead transcription factor Foxp3 is specifically expressed in regulatory CD4 T cells and is required for their development and function. Although identification of Foxp3 as a critical molecular mechanism establishing regulatory T cell differentiation program is a major breakthrough, it remains unknown what are Foxp3 target genes essential for this program. In addition, our findings raise an important question as to why there is such a discrepancy in the severity and onset of the autoimmune syndrome in a genetic model of CD25+ CD4 regulatory T cell deficiency in Foxp3 deficient mice and in murine models relying on elimination of CD25+ CD4 T cells. We propose several possible non-mutually exclusive hypotheses to explain this apparent controversy: a) In addition to CD25+ CD4 T cells, Foxp3 is expressed by an unidentified subset(s) of CD25- CD4 or CD8 T cells with the regulatory function capable of providing some measure of protection from autoimmunity in mice subjected to acute depletion of CD25+ CD4 T cells; b) In the absence of Foxp3, T cells with an increased TCR affinity for self peptide/MHC class II complexes that normally develop into regulatory CD25+ CD4 T cells instead become pathogenic and largely responsible for the rapid disease progression; c) A subset of CD25+ CD4 T cells with autoreactive TCR lack Foxp3 and may represent a major population of autoreactive T cells normally controlled by Foxp3 expressing CD25+ CD4 regulatory T cells; d) Foxp3 expressed at a low level in nonregulatory CD4 T cells controls thresholds of activation, dependence on co-stimulation, or anergy induction. In this proposal we will address the aforementioned questions using genetic approaches including Foxp3 protein and mRNA reporter mice, conditional deletion and induced expression of Foxp3 gene in vivo and in vitro in combination with functional and molecular analyses. The following specific Aims will be pursued: 1. To investigate Foxp3 protein and mRNA expression and their regulation during thymic development (Aim 1a) and a role for Foxp3 in negative selection of T cells in the thymus and to evaluate autoreactivity of T cells with the Foxp3 deletion (Aim 1b). 2. To investigate Foxp3 protein and mRNA expression and to assess regulatory function of distinct Foxp3+ T cell subsets (Aim2a); to investigate Foxp3 protein and mRNA regulation in peripheral T cells and to explore, thereby, possible generation of Foxp3+ T cells in the periphery (Aim 2b); to test a requirement for Foxp3 expression in maintaining regulatory T cell function (Aim 2c). 3. To investigate potential cell-intrinsic role of Foxp3 in controlling activation, central and peripheral tolerance induction in non-regulatory CD25- CD4 T cells. 4. To identify molecular targets of the Foxp3 gene involved in regulation of regulatory T cell development and function.
描述(由申请人提供):自然产生的CD25+CD4T细胞在调节免疫动态平衡方面起着重要作用。然而,调控它们分化和活性的具体分子机制在很大程度上还不清楚。我们发现叉头转录因子Foxp3在调节性的CD4T细胞中特异表达,是其发育和功能所必需的。尽管Foxp3作为建立调节性T细胞分化程序的关键分子机制的鉴定是一项重大突破,但目前仍不清楚Foxp3对该程序至关重要的靶基因是什么。此外,我们的发现提出了一个重要的问题,即为什么在Foxp3缺陷小鼠中CD25+CD4调节性T细胞缺陷的遗传模型中,自身免疫综合征的严重程度和发病情况与依赖CD25+CD4T细胞消除的小鼠模型中存在如此大的差异。我们提出了几种可能的非互斥假设来解释这一明显的争议:a)除了CD25+CD4T细胞外,Foxp3是由一种未鉴定的CD25-CD4T细胞或CD8T细胞亚群(S)表达的,具有调节功能,能够在CD25+CD4T细胞急性耗尽的小鼠中提供一定程度的自身免疫保护;b)在没有Foxp3的情况下,T细胞对自体多肽/MHC II类复合体的TCR亲和力增加,正常情况下发展为CD25+CD4T细胞,但却成为致病的,并在很大程度上导致疾病的快速发展;C)具有自身反应性TCR的CD25+CD4T细胞亚群缺乏Foxp3,可能代表通常由表达CD25+CD4调节性T细胞的Foxp3控制的大部分自身反应性T细胞;d)在非调节性CD4T细胞中低水平表达Foxp3控制激活、对共刺激的依赖性或无能诱导的阈值。在本提案中,我们将利用遗传学方法,包括Foxp3蛋白和mRNA报告小鼠,体内和体外Foxp3基因的条件缺失和诱导表达,并结合功能和分子分析来解决上述问题。1.研究Foxp3蛋白和信使核糖核酸在胸腺发育过程中的表达及其调控(目标1a),以及Foxp3在胸腺T细胞阴性选择中的作用,并评价缺失Foxp3的T细胞的自身反应性(目标1b)。2.研究不同Foxp3+T细胞亚群(Aim2a)的Foxp3蛋白和mRNA的表达及其调节功能;研究外周T细胞中Foxp3蛋白和mRNA的调节,从而探索外周Foxp3+T细胞的可能产生(Aim 2b);检测维持调节性T细胞功能对Foxp3表达的要求(Aim 2c)。3.探讨Foxp3在调控非调节性CD25-CD4T细胞活化、中枢和外周耐受诱导中的潜在细胞内在作用。4.确定Foxp3基因参与调节T细胞发育和功能的分子靶点。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.
- DOI:10.1038/ni.1795
- 发表时间:2009-11
- 期刊:
- 影响因子:30.5
- 作者:
- 通讯作者:
Control of regulatory T cell lineage commitment and maintenance.
- DOI:10.1016/j.immuni.2009.04.009
- 发表时间:2009-05
- 期刊:
- 影响因子:32.4
- 作者:Josefowicz SZ;Rudensky A
- 通讯作者:Rudensky A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Y Rudensky其他文献
Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells
Runx-CBFβ复合物控制调节性 T 细胞中转录因子 Foxp3 的表达
- DOI:
10.1038/ni.1795 - 发表时间:
2009-09-20 - 期刊:
- 影响因子:27.600
- 作者:
Dipayan Rudra;Takeshi Egawa;Mark M W Chong;Piper Treuting;Dan R Littman;Alexander Y Rudensky - 通讯作者:
Alexander Y Rudensky
TGFβ signalling in control of T-cell-mediated self-reactivity
转化生长因子β信号在控制 T 细胞介导的自身反应性中的作用
- DOI:
10.1038/nri2095 - 发表时间:
2007-06-01 - 期刊:
- 影响因子:60.900
- 作者:
Yuri P Rubtsov;Alexander Y Rudensky - 通讯作者:
Alexander Y Rudensky
DNA methylation secures CD4+ and CD8+ T cell lineage borders
DNA 甲基化确保 CD4+ 和 CD8+ T 细胞谱系边界
- DOI:
10.1038/ni.3207 - 发表时间:
2015-06-18 - 期刊:
- 影响因子:27.600
- 作者:
Yongqiang Feng;Alexander Y Rudensky - 通讯作者:
Alexander Y Rudensky
Foxp3 in control of the regulatory T cell lineage
Foxp3 控制调节性 T 细胞谱系
- DOI:
10.1038/ni1455 - 发表时间:
2007-04-17 - 期刊:
- 影响因子:27.600
- 作者:
Ye Zheng;Alexander Y Rudensky - 通讯作者:
Alexander Y Rudensky
Regulatory T cells in the context: deciphering the dynamic interplay with the tissue environment
背景中的调节性 T 细胞:解读与组织环境的动态相互作用
- DOI:
10.1016/j.coi.2024.102453 - 发表时间:
2024-08-01 - 期刊:
- 影响因子:5.800
- 作者:
Xiao Huang;Alexander Y Rudensky - 通讯作者:
Alexander Y Rudensky
Alexander Y Rudensky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Y Rudensky', 18)}}的其他基金
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
项目二:原发性结肠癌及淋巴结和肝转移的免疫调节回路
- 批准号:
10525193 - 财政年份:2022
- 资助金额:
$ 12.02万 - 项目类别:
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
项目二:原发性结肠癌及淋巴结和肝转移的免疫调节回路
- 批准号:
10705782 - 财政年份:2022
- 资助金额:
$ 12.02万 - 项目类别:
The tumor ecosystem in cancer progression and immunotherapeutic response
癌症进展和免疫治疗反应中的肿瘤生态系统
- 批准号:
9980809 - 财政年份:2016
- 资助金额:
$ 12.02万 - 项目类别:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
- 批准号:
7437301 - 财政年份:2004
- 资助金额:
$ 12.02万 - 项目类别:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
- 批准号:
7068032 - 财政年份:2004
- 资助金额:
$ 12.02万 - 项目类别:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
- 批准号:
6828596 - 财政年份:2004
- 资助金额:
$ 12.02万 - 项目类别:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
- 批准号:
7228505 - 财政年份:2004
- 资助金额:
$ 12.02万 - 项目类别:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
调节 T 细胞发育的分子机制
- 批准号:
6896917 - 财政年份:2004
- 资助金额:
$ 12.02万 - 项目类别:
ROLE OF CATHEPSINS S, L AND B IN THE TYPE 1 DIABETES
组织蛋白酶 S、L 和 B 在 1 型糖尿病中的作用
- 批准号:
6575967 - 财政年份:2002
- 资助金额:
$ 12.02万 - 项目类别:
ROLE OF CATHEPSINS S, L AND B IN THE TYPE 1 DIABETES
组织蛋白酶 S、L 和 B 在 1 型糖尿病中的作用
- 批准号:
6666916 - 财政年份:2002
- 资助金额:
$ 12.02万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 12.02万 - 项目类别:
Research Grant